What BIO Deutschland does

BIO Deutschland e.V. is a German registered non-profit association (eingetragener Verein) founded in 2004 and headquartered in Berlin at Schützenstraße 6a. It operates as the sector association of the German biotechnology industry, representing several hundred member companies that span the full biotechnology value chain, from industrial bioeconomy (white biotechnology, biorefineries, bioplastics, enzymes) to health and biopharmaceutical applications. Its membership base includes both innovative small and medium-sized enterprises (SMEs) and major multinational corporations such as Bayer, Boehringer Ingelheim, Roche, Sanofi, Thermo Fisher, Evotec, QIAGEN, Miltenyi Biotec, and AGC Biologics.

The association generates revenue through recurring annual membership fees, the pricing of which is not publicly disclosed. Rather than commercial products, BIO Deutschland delivers a portfolio of member services: substantive working groups covering Industrial Bioeconomy, AI and Digital Innovation, Diagnostics, Financing/Taxation, Health Policy, Industrial Cell Technology, Regulatory Affairs, Protection Rights and Technical Contracts, and Technology Transfer; the German Biotech Days annual conference held in cities such as Leipzig; an Innovation Prize administered with the Council of German BioRegions (AK BioRegio); annual industry surveys dating back over a decade; position papers on biotechnology policy; and legal advisory services for members.

BIO Deutschland's strategic positioning centers on advocacy at both national and EU levels. It is an active stakeholder in the EU Biotech Act initiative launched by the European Commission in December 2025, participates in international coordination through the BIO-Europe Innovation Statement alongside EuropaBio and EFPIA, and engages with financing ecosystem partners including the European Investment Bank's planned BiotechEU instruments and the WIN Initiative. The organization is led by a Board, currently under President Oliver Schacht, with a lean operational staff of 1-10 employees, and is connected to broader German innovation infrastructure including BMWK programs (EXIST, GO-Bio), SPRIND, and DATI.

Name

BIO Deutschland

Legal name

BIO Deutschland e. V.

Website

https://biodeutschland.org

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

1–10 employees

Short description

BIO Deutschland e.V. is a Berlin-based, non-profit industry association representing several hundred German biotechnology companies, including SMEs and major pharma firms, through advocacy, working groups, events, and policy engagement at national and EU levels.

Ownership category

akta.pro rank

Product category

Biotechnology Industry Association

NAICS

Professional Organizations (813920), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Membership Organizations (8600), Services-Health Services (8000)

akta.pro primary industry

Technical Committees, Working Groups & Expert Panels (BPADANAB)

akta.pro secondary industries

Health, Pharmaceuticals & Medical Devices Regulatory Cooperation (BPADANAJ), Bio-based Pharmaceuticals, Nutraceuticals & Specialty Bioactives (EUAAAIAK), Bio-based Food & Flavor Ingredients (Non-fuel Co-products: sweeteners, organic acids, flavors) (EUAAAIAJ), Synthetic Biology & Genetic Circuit Design Platforms (pathway engineering, chassis development) (HLAAAIAD)

Keywords

• Biotechnology industry association
• Industry policy advocacy
• Biotech networking events
• Regulatory working groups
• Biotech industry surveys

Headquarters

HQ city

Berlin

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Membership Fees: BIO Deutschland generates revenue through membership fees from biotech companies, particularly small and medium-sized enterprises (SMEs) active in the industrial biotechnology sector.

Pricing tiers

Distribution channels1 record

Marketing channels5 records

Core offering

BIO Deutschland is a non-profit sector association of the German biotechnology industry, registered as an eingetragener Verein (e.V.). It represents biotech companies through membership, provides policy advocacy at national and EU levels, runs substantive working groups across topics such as industrial bioeconomy, AI and digital innovation, diagnostics, financing, health policy, regulatory affairs, and technology transfer, and convenes the industry through the annual German Biotech Days conference and Innovation Prize program.

Product overview

BIO Deutschland is a biotechnology industry association in Germany that represents companies active in the industrial biotechnology sector, particularly innovative small and medium-sized enterprises (SMEs). Rather than offering commercial products, the association provides services including working groups on topics such as Industrial Bioeconomy, AI and Digital Innovation, Diagnostics, Financing/Taxation, Health Policy, Industrial Cell Technology, Regulatory Affairs, Protection Rights and Technical Contracts, and Technology Transfer. The association also facilitates networking through the Council of German BioRegions, organizes the German Biotech Days annual event, manages an Innovation Prize, conducts annual company surveys, and publishes position papers on biotechnology policy and industry advocacy. BIO Deutschland does not offer commercial software products, platforms, or APIs.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• Active participation in EU Biotech Act development with €1bn EIB financing instrument for biotech
• +1 more outcomes

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Eight partnerships are on record, tiered core, major and minor.

• Council of German BioRegions (AK BioRegio)coreStrategic or Co-development PartnerBIO Deutschland hosts the Council of German BioRegions (AK BioRegio), which promotes the importance of bioeconomy in Germany and the EU. The council includes German biotech regions and organizes the German Biotech Days annual conference and Innovation Prize.
• International Biotechnology Associations (EuropaBio, EFPIA, and others)coreStrategic or Co-development PartnerBIO Deutschland collaborates with international biotechnology associations including EuropaBio and EFPIA. In February 2026, biotechnology associations from three continents convened at BIO-Europe in Vienna and issued an inaugural Innovation Statement identifying key bottlenecks to robust biotechnology sectors and proposing solutions for global collaboration and regulatory harmonization.
• European Commission / EU Biotech Act InitiativecoreStrategic or Co-development PartnerBIO Deutschland is a key stakeholder in the EU Biotech Act development. Industry stakeholders including EuropaBio, EFPIA, and BioDeutschland welcomed the initiative proposed by the European Commission on December 16, 2025, which includes measures to speed up clinical trials, reduce regulatory hurdles, and support biotech scale-ups in Europe.
• WIN Initiative (Wirtschaft Initiative Deutschland)majorStrategic or Co-development PartnerUnder the WIN initiative launched September 2024, businesses, industry associations, policymakers, and KfW formed an alliance to establish Germany as a leading financing hub. Participating businesses pledged to invest €12 billion by 2030 to strengthen the German venture capital ecosystem.
• German Federal Ministry for Economic Affairs and Climate Action (BMWK)coreStrategic or Co-development PartnerThe BMWK supports programs like EXIST for life science start-ups and the recently relaunched GO-Bio (Gründungsoffensive Biotechnologie) funding program tailored to biotech sector challenges.
• beLAB2122 BRIDGE PartnershipmajorStrategic or Co-development PartnerPartnership between German Cancer Research Center (DKFZ), European Molecular Biology Laboratory (EMBL), Universities of Heidelberg, Frankfurt and Tübingen, and companies Evotec and Bristol Myers Squibb to enable dual career paths between academia and industry.
• SPRIND (German Federal Agency for Breakthrough Innovation)majorStrategic or Co-development PartnerSPRIND supports start-ups based on promising disruptive inventions. The SPRIND Freedom Act has significantly bolstered the agency's ability to carry out its mandate for supporting breakthrough innovation in Germany.
• DATI (German Agency for Transfer and Innovation)minorStrategic or Co-development PartnerThe German Agency for Transfer and Innovation, a product of the 2021 coalition agreement, is in the process of being founded to promote innovation communities at the regional level.

Scale indicators3 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• France Biotech: French biotechnology industry association; directly comparable national association serving French biotech SMEs and representing France in EU policy discussions alongside BIO Deutschland.
• BIA (BioIndustry Association, UK): UK biotechnology trade association; structurally equivalent national biotech association serving UK SMEs and larger members, with similar working groups and advocacy focus.
• Swiss Biotech Association: National biotechnology industry association of Switzerland; directly comparable as a small-country national biotech association with similar SME-focused mandate and EU adjacency.
• EFPIA (European Federation of Pharmaceutical Industries and Associations): European pharma industry association; partner association to BIO Deutschland and overlaps in advocacy on EU biotech/pharma regulatory and financing policy.
• EuropaBio: European biotechnology industry association based in Brussels; directly comparable as the pan-European counterpart to BIO Deutschland and a co-collaborator on EU Biotech Act advocacy.
• Netherlands Biotech Association (HollandBIO): Dutch biotechnology industry association serving SMEs and larger members; comparable national biotech trade association with similar SME-focused mandate.

Broad incumbents

• BIO (Biotechnology Innovation Organization): The largest US biotechnology trade association; serves as the global benchmark for national biotech associations and is the US counterpart to BIO Deutschland's mandate.

Regional players

• vfa (Verband forschender Arzneimittelhersteller): German research-based pharmaceutical industry association; overlaps significantly with BIO Deutschland in German pharma/biotech advocacy but focused on the pharma side, providing a complementary voice.
• Pharma Deutschland: German pharmaceutical industry umbrella association; operates in adjacent pharma policy space in Germany and partially overlaps with BIO Deutschland's health policy advocacy.

Others

• BIO Deutschland Members - Council of German BioRegions (AK BioRegio): Network of German biotech regional clusters hosted by BIO Deutschland; comparable as a regional cluster-association ecosystem rather than a direct competitor.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/BIODeutschland
• LinkedInlinkedin.com/company/bio-deutschland-e.-v.

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BIO Deutschland